20
Dr. Reddy's Laboratories Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their significant offerings is Rivastigmine hydrogen tartrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2013-305 - Rev 00
This Chemical Type CEP, issued on January 13, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2630 associated with this CEP further emphasizes